🔎 Trials Near Me

Inicio › Leucemia bifenotípica aguda › Georgia

Ensayos clínicos de Leucemia bifenotípica aguda en Georgia

9 estudios sobre Leucemia bifenotípica aguda buscan participantes en Georgia.

Ciudades en Georgia

Texto oficial del estudio (inglés)

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

  • Emory University, Atlanta
ReclutandoFase 1
Edades de 12 a 78 · Todos los sexos · Actualizado el 29 sept 2026 · NCT03802695

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
ReclutandoFase 2
365 Days · Todos los sexos · Actualizado el 25 sept 2026 · NCT06317662

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

  • Emory Winship Cancer Institute, Atlanta
ReclutandoFase 1/2
30 Days · Todos los sexos · Actualizado el 16 sept 2026 · NCT04065399

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
  • Memorial Health University Medical Center, Savannah
ReclutandoFase 1/2
Hasta los 22 · Todos los sexos · Actualizado el 25 ago 2026 · NCT04726241

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
  • Augusta University Medical Center, Augusta
  • Atrium Health Navicent, Macon
  • y 1 más
ReclutandoFase 3
365 Days – 25 Years · Todos los sexos · Actualizado el 25 ago 2026 · NCT03959085

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

  • Children's Healthcare of Atlanta, Atlanta
ReclutandoFase 1
Edades de 1 a 30 · Todos los sexos · Actualizado el 3 ago 2026 · NCT06177067

Venetoclax Basket Trial for High Risk Hematologic Malignancies

  • Children's Healthcare of Atlanta at Arthur M. Blank Hospital, Atlanta
ReclutandoFase 1
Edades de 1 a 40 · Todos los sexos · Actualizado el 12 mar 2026 · NCT05292664

Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL

  • Emory University - WINSHIP Cancer Center, Atlanta
  • Emory University, Children's Healthcare of Atlanta, Atlanta
ReclutandoFase 1
Edades de 12 en adelante · Todos los sexos · Actualizado el 8 ene 2026 · NCT04872478

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

  • Children's Healthcare of Atlanta, Emory University, Atlanta
ReclutandoFase 1
Edades de 1 a 21 · Todos los sexos · Actualizado el 6 dic 2024 · NCT05476770

De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.